- Tytuł:
- Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
- Autorzy:
- Źródło:
- In The Lancet 11-17 September 2021 398(10304):981-990
Czasopismo naukowe